Hereditary tyrosinemia and the heme biosynthetic pathway. Profound inhibition of delta-aminolevulinic acid dehydratase activity by succinylacetone
about
Cloning and expression of the defective genes from a patient with delta-aminolevulinate dehydratase porphyriaOral loading of homogentisic acid in controls and in obligate heterozygotes for hereditary tyrosinemia type IRole of delta-aminolevulinic acid in the symptoms of acute porphyriaPoint mutations in the murine fumarylacetoacetate hydrolase gene: Animal models for the human genetic disorder hereditary tyrosinemia type 1Hereditary tyrosinaemia type I: from basics to progress in treatment.The dichloroacetate dilemma: environmental hazard versus therapeutic goldmine--both or neither?Experience of nitisinone for the pharmacological treatment of hereditary tyrosinaemia type 1.Mice deficient in glutathione transferase zeta/maleylacetoacetate isomerase exhibit a range of pathological changes and elevated expression of alpha, mu, and pi class glutathione transferasesHepatocyte injury in tyrosinemia type 1 is induced by fumarylacetoacetate and is inhibited by caspase inhibitors.Porphyria Diagnostics-Part 1: A Brief Overview of the Porphyrias.Alkaptonuria: leading to the treasure in exceptions.Synthesis, delivery and regulation of eukaryotic heme and Fe-S cluster cofactors.A precursor-inducible zebrafish model of acute protoporphyria with hepatic protein aggregation and multiorganelle stress.Hypermethioninemias of genetic and non-genetic origin: A review.Hereditary Tyrosinemia Type 1 in Turkey.Chemistry and biology of heme. Effect of metal salts, organometals, and metalloporphyrins on heme synthesis and catabolism, with special reference to clinical implications and interactions with cytochrome P-450.Porphobilinogen synthase from the butterfly, Pieris brassicae: purification and comparative characterization.Upregulated heme biosynthesis, an exploitable vulnerability in MYCN-driven leukemogenesis.Regulatory heme and trichloroethylene intoxication: A possible explanation of the case of "A Civil Action".Purification and properties of 5-aminolaevulinate dehydratase from human erythrocytes.Expression of 5-aminolaevulinate synthase and cytochrome P-450 mRNAs in chicken embryo hepatocytes in vivo and in culture. Effect of porphyrinogenic drugs and haem.Hereditary tyrosinemia. Formation of succinylacetone-amino acid adducts.Gene-environmental interactions: Lessons from porphyria.delta-Aminolaevulinate synthase in human HepG2 hepatoma cells. Repression by haemin and induction by chemicals.Nucleation-conversion-polymerization reactions of biological macromolecules with prenucleation clusters.Molecular docking studies of disubstituted diaryl diselenides as mammalian δ-aminolevulinic acid dehydratase enzyme inhibitors.Neurological and Neuropsychological Problems in Tyrosinemia Type I Patients.Tyrosinemia type I and not treatment with NTBC causes slower learning and altered behavior in mice.Best practice guidelines on first-line laboratory testing for porphyria.
P2860
Q24564883-28E448CE-13C5-4C10-89A9-1A68F6861209Q28335698-C4D64145-5988-4D03-967A-A87199C608D4Q28388495-18ECC154-B8B0-437E-9414-FF0AD686ADA1Q28510201-533C5788-47F3-4A7C-947E-4ECBE5BD85A7Q34111877-C5D2F7A5-D2B0-471B-B202-7A8C371320F6Q34580854-ED0D2887-5332-4AAB-810C-9125BBF722E2Q34590786-E0D87420-47B4-478D-8382-7C5D1D248BFDQ35102961-06FF2810-7D21-4550-8322-093E308DDA6FQ36266189-D7297646-5622-42C6-A7A0-8ECE7D9682E2Q36267789-1955F9C6-CC30-4630-A211-2313FF0811A9Q36433474-38A54897-090E-43E5-8995-99A8D60B2A95Q36667724-571CF1FE-779E-493F-8E26-FAD4B2BAA24EQ36812059-BDE06426-A089-41E2-A8A3-53198F328C31Q37838882-43630553-80E4-41AB-ABE3-33DF06C6E4B8Q38654156-242C669C-AD9F-419E-9960-546E027EDD17Q40884181-0EF8DA6F-C6D5-4240-A60E-E9648AA20FA9Q41121100-A30799F1-349F-4D30-920F-29F50AB65E36Q41252330-43A040A8-00AD-4B92-9EE2-631BB5516C41Q41890329-82B68C76-072A-4964-9B85-5B2BC0FAFF9FQ41974813-1F506C0E-4D9E-47DD-AF85-B6D589A1E78DQ42144078-0A351264-AE25-49B5-A041-936642D27B09Q42637714-CFC7A389-626C-4DFA-929C-A9A270A99F0DQ42699206-D5D991C2-A2EC-4C4C-964A-BB11939E3419Q42803090-8AFA7434-F8C5-45FA-A437-DE79DB47B864Q46905865-522630BC-070C-4E4B-8BAB-033825252A1FQ47315436-D3080D77-BBE6-4236-8BED-D0E6917B17F4Q47762401-1805792D-F0DB-499A-AD33-A20B412BEE21Q50506402-64D7108D-533D-401B-A278-9E3299930718Q50592268-4D73B8B5-9E30-42BF-9650-FB59038567B1
P2860
Hereditary tyrosinemia and the heme biosynthetic pathway. Profound inhibition of delta-aminolevulinic acid dehydratase activity by succinylacetone
description
1983 nî lūn-bûn
@nan
1983 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1983 թվականի մարտին հրատարակված գիտական հոդված
@hy
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
name
Hereditary tyrosinemia and the ...... se activity by succinylacetone
@ast
Hereditary tyrosinemia and the ...... se activity by succinylacetone
@en
Hereditary tyrosinemia and the ...... se activity by succinylacetone
@nl
type
label
Hereditary tyrosinemia and the ...... se activity by succinylacetone
@ast
Hereditary tyrosinemia and the ...... se activity by succinylacetone
@en
Hereditary tyrosinemia and the ...... se activity by succinylacetone
@nl
prefLabel
Hereditary tyrosinemia and the ...... se activity by succinylacetone
@ast
Hereditary tyrosinemia and the ...... se activity by succinylacetone
@en
Hereditary tyrosinemia and the ...... se activity by succinylacetone
@nl
P2860
P356
P1476
Hereditary tyrosinemia and the ...... se activity by succinylacetone
@en
P2093
P2860
P304
P356
10.1172/JCI110809
P407
P577
1983-03-01T00:00:00Z